- Home
- Publications
- Publications Database
-
A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Daniel Umbricht, Marta del Valle Rubido, Eric Hollander, James T. McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante, Christophe Grundschober, Heidemarie Kletzl, Paulo Fontoura
- Title
- A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder.
- Journal
- Neuropsychopharmacology
- Year
- 2016
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Peer-Reviewed, Randomised Trial, Controlled Trial, Multisite, Double Blind, Placebo
- Comments
- ClinicalTrials.gov identifier: NCT01474278
- Keywords
- Adult, Autism, Autistic Disorder, Communication Skills, High Functioning, Intervention, Medication, RG7713, Social Skills, Vasopressin 1a Receptor Antagonist
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.